September 14th, 2022


A patent related to T-ignite® technology granted in Canada.

A patent for UI-101 and UI-201 (CA2925658 A1, “T cell inducing vaccine containing an inter-epitope sequence that promotes antigen presentation”), which we hold an exclusive license, was granted in Canada. The family patents have been also issued in the US(US11179450)and Japan (JP6558699).